Pain management in cancer survivorship

Acta Oncologica

Volumn 54, Issue 5, 2015, Pages 629-634

  Kurita, Geana Paula ^a   Sjøgren, Per ^a,b  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; NARCOTIC ANALGESIC AGENT;

ANALGESIA; BREAST CANCER; CANCER PAIN; CANCER SURVIVOR; CHRONIC PAIN; COGNITIVE THERAPY; DATA BASE; HUMAN; NEUROPATHIC PAIN; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; SELF REPORT; ADULT; BREAST NEOPLASMS; COMPLICATION; FEMALE; MALE; MIDDLE AGED; NEOPLASMS; NEURALGIA; PROCEDURES; SURVIVOR;

ADULT; ANALGESICS; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BREAST NEOPLASMS; CHRONIC PAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEURALGIA; PAIN MANAGEMENT; PHYSICAL THERAPY MODALITIES; SURVIVORS;

EID: 84928776526     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2014.996662     Document Type: Review

References (29)

1. National Cancer Institute. NCI Dictionary of cancer terms. [cited 2014 Jul 8]. Available from: http://www.cancer.gov/dictionary?cdrid =450125
2. Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: A critical review of risk factors and strategies for prevention. J Pain 2011; 12: 725-46.
3. Gärtner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 2009; 302: 1985-92.
4. Peuckmann V, Ekholm O, Rasmussen NK, Groenvold M, Christiansen P, Møller S, et al. Chronic pain and other sequelae in long-term breast cancer survivors: Nationwide survey in Denmark. Eur J Pain 2009; 13: 478-85.
5. Davidsen M, Kjoller M, Helweg-Larsen K. The Danish National Cohort Study (DANCOS). Scand J Public Health 2011; 39: 131-5.
6. Schou Bredal I, Smeby NA, Ottesen S, Warncke T, Schlichting E. Chronic pain in breast cancer survivors: Comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain. Pain Symptom Manage 2014; 48: 852-62.
7. Bell RJ, Robinson PJ, Nazeem F, Panjari M, Fradkin P, Schwarz M, et al. Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. J Cancer Surviv 2014; 8: 1-8.
8. Belfer I, Schreiber KL, Shaffer JR, Shnol H, Blaney K, Morando A, et al. Persistent postmastectomy pain in breast cancer survivors: Analysis of clinical, demographic, and psychosocial factors. J Pain 2013; 14: 1185-95.
9. Forsythe LP, Alfano CM, George SM, McTiernan A, Baumgartner KB, Bernstein L, et al. Pain in long-term breast cancer survivors: The role of body mass index, physical activity, and sedentary behavior. Breast Cancer Res Treat 2013; 137: 617-30.
10. Schreiber KL, Martel MO, Shnol H, Shaffer JR, Greco C, Viray N, et al. Persistent pain in postmastectomy patients: comparison of psychophysical, medical, surgical, and psychosocial characteristics between patients with and without pain. Pain 2013; 154: 660-8.
11. Peuckmann V, Ekholm O, Rasmussen NK, Møller S, Groenvold M, Christiansen P, et al. Health-related quality of life in long-term breast cancer survivors: Nationwide survey in Denmark. Breast Cancer Res Treat 2007; 104: 39-46.
12. Jensen TS, Baron R, Haanpaa M, Kalso E, Loeser JD, Rice AS, et al. A new definition of neuropathic pain. Pain 2011; 152: 2204-5.
13. Haanpaa M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, et al. Neu PSIG guidelines on neuropathic pain assessment. Pain 2011; 152: 14-27.
14. Mulvey MR, Rolke R, Klepstad P, Caraceni A, Fallon M, Colvin L, et al. On behalf of the IASP Cancer Pain SIGand the EAPC Research Network. Confirming neuropathic pain in cancer patients: Applying the Neu PSIG grading system in clinical practice and clinical research. Pain 2014; 155: 859-63.
15. Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpää ML, et al. Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clin Proc 2010; 85: S3-14.
16. Brunelli C, Bennett MI, Kaasa S, Fainsinger R, Sjogren P, Mercadante S, et al.; EAPC Research Network and the IASP Cancer Pain SIG. Classification of neuropathic pain in cancer patients: A Delphi expert survey report and EAPC/IASPproposal of an algorithm for diagnostic criteria. Pain 2014; 155: 2707-13.
17. Kurita GP, Sjøgren P. Prescribing opioids for chronic noncancer pain: Predicting response and assessing risk factors. Pain Manage 2013; 3: 325-8.
18. Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: Therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology 2013; 21: 201-32.
19. Atchison JW1, Herndon CM, Rusie E. NSAIDs for musculoskeletal pain management: Current perspectives and novel strategies to improve safety. J Manage Care Pharm 2013; 19: S3-19.
20. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150: 573-81.
21. Mishra S, Bhatnagar S, Goyal GN, Rana SP, Upadhya SP. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: A prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care 2012; 29: 177-82.
22. Bennett MI, Simpson KH. Gabapentin in the treatment of neuropathic pain. Palliat Med 2004; 18: 5-11.
23. Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, et al; Alliance for Clinical Trials in Oncology. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: A randomized clinical trial. JAMA 2013; 309: 1359-67.
24. Højsted J, Nielsen PR, Guldstrand SK, Frich L, Sjøgren P. Classification and identification of opioid addiction in chronic pain patients. Eur J Pain 2010; 14: 1014-20.
25. Lennon FE, Moss J, Singleton PA. The μ-opioid receptor in cancer progression: Is there a direct effect? Anesthesiology 2012; 116: 940-5.
26. Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000; 85: 2215-22.
27. Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, et al. Survivorship: Pain version 1. 2014. J Natl Compr Canc Netw 2014; 12: 488-500.
28. Zheng M, Peltz G. Genetic discovery: The prescription for chronic pain. Genome Med 2010; 2: 82.
29. Shipton EA. The transition from acute to chronic post surgical pain. Anaesth Intensive Care 2011; 39: 824-36.